Multikinase Inhibitor-Related Skin Toxicity (Recently Updated)

GI CONNECT has identified the Management of Skin Toxicities from Multikinase Inhibitor Therapies (MKIs) on the ESMO OncologyPro portal as a practical guide on how to prevent and treat skin toxicities form MKIs.